Complications, GVHD, and outcome*
Toxicity . | No. of patients . | ||
---|---|---|---|
Group A . | Group B . | All . | |
Stomatitis | |||
< 3rd degree | 5 | 15 | 20 |
3rd or 4th degree | 9 | 1 | 10 |
Gastrointestinal tract | |||
< 3rd degree | 9 | 11 | 20 |
3rd or 4th degree | 5 | 5 | 10 |
Liver† | |||
< 3rd degree | 8 | 8 | 16 |
3rd or 4th degree | 6 | 8 | 14 |
Kidney‡ | |||
< 3rd degree | 12 | 12 | 24 |
3rd or 4th degree | 2 | 4 | 6 |
Lung | |||
< 3rd degree | 12 | 11 | 23 |
3rd or 4th degree | 2 | 5 | 7 |
Heart | |||
< 3rd degree | 12 | 15 | 27 |
3rd or 4th degree | 2 | 1 | 3 |
Acute GVHD | |||
< grade 2 | 8 | 11 | 19 |
Grade 2 | 4 | 5 | 9 |
Grade 3 | 1 | 0 | 1 |
Grade 4 | 1 | 0 | 1 |
Chronic GVHD (in evaluable patients) | |||
None | 7 | 11 | 18 |
Limited | 2 | 2 | 4 |
Extended | 2 | 3 | 5 |
Rejection and relapse | |||
Graft rejection | 1 | 1 | 2 |
Relapse of disease | 6 | 1 | 7 |
Treatment-related mortality | 2 | 2 | 4 |
Dead | 5 | 2 | 7 |
Alive | 9 | 14 | 23 |
Toxicity . | No. of patients . | ||
---|---|---|---|
Group A . | Group B . | All . | |
Stomatitis | |||
< 3rd degree | 5 | 15 | 20 |
3rd or 4th degree | 9 | 1 | 10 |
Gastrointestinal tract | |||
< 3rd degree | 9 | 11 | 20 |
3rd or 4th degree | 5 | 5 | 10 |
Liver† | |||
< 3rd degree | 8 | 8 | 16 |
3rd or 4th degree | 6 | 8 | 14 |
Kidney‡ | |||
< 3rd degree | 12 | 12 | 24 |
3rd or 4th degree | 2 | 4 | 6 |
Lung | |||
< 3rd degree | 12 | 11 | 23 |
3rd or 4th degree | 2 | 5 | 7 |
Heart | |||
< 3rd degree | 12 | 15 | 27 |
3rd or 4th degree | 2 | 1 | 3 |
Acute GVHD | |||
< grade 2 | 8 | 11 | 19 |
Grade 2 | 4 | 5 | 9 |
Grade 3 | 1 | 0 | 1 |
Grade 4 | 1 | 0 | 1 |
Chronic GVHD (in evaluable patients) | |||
None | 7 | 11 | 18 |
Limited | 2 | 2 | 4 |
Extended | 2 | 3 | 5 |
Rejection and relapse | |||
Graft rejection | 1 | 1 | 2 |
Relapse of disease | 6 | 1 | 7 |
Treatment-related mortality | 2 | 2 | 4 |
Dead | 5 | 2 | 7 |
Alive | 9 | 14 | 23 |